| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/30/2009 | US20090113574 Expressed Sequence Tags (ESTs) isolated from soybean; used in isolating genes and promoters, identifying and mapping the genes involved in developmental and metabolic pathways, and determining gene function |
| 04/30/2009 | US20090113573 Modification of Flavonoid Biosynthesis in Plants |
| 04/30/2009 | US20090113571 Root-specific phosphate transporter promoters |
| 04/30/2009 | US20090111977 Antisense compound for inducing immunological tolerance |
| 04/30/2009 | US20090111976 Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same |
| 04/30/2009 | US20090111974 Treatment of Liver Cirrhosis and Its Complications |
| 04/30/2009 | US20090111968 Self-assembled proteins and related methods and protein structures |
| 04/30/2009 | US20090111767 Modulation of insulin like growth factor i receptor expression |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111754 Selective Inhibitors of Nuclear Factor KappaB Activation and Uses Thereof |
| 04/30/2009 | US20090111738 Fibronectin polypeptides and methods of use |
| 04/30/2009 | US20090111712 Detection and quantification of biomolecules using mass spectrometry |
| 04/30/2009 | US20090111708 Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
| 04/30/2009 | US20090111187 Moss Expressing Promotion Regions |
| 04/30/2009 | US20090111186 regulatory nucleotide sequence for obtaining a transformed plants and seeds; increase in yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance and salt tolerance in plants |
| 04/30/2009 | US20090111170 Nucleic acid processing methods, kits and devices |
| 04/30/2009 | US20090111161 Isolated protein comprising a serine protease consisting of an amino acid sequence that is at least 95% identical to the Streptomyces 1AG3 protease; cleaning composition containing aforementioned protein |
| 04/30/2009 | US20090111160 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis |
| 04/30/2009 | US20090111159 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 04/30/2009 | US20090111155 Modified xylanase exhibiting improved expression |
| 04/30/2009 | US20090111123 Compositions for detecting antibodies to babesia microti and methods of uses thereof |
| 04/30/2009 | US20090111113 Solid support having electrostatic layer and use thereof |
| 04/30/2009 | US20090111107 Tumor suppressor gene p33ing2 |
| 04/30/2009 | US20090111103 Method for measuring the number of oral lactobacillus, and a pcr primers-probe set used for the same |
| 04/30/2009 | US20090111100 Minor groove binder - energy transfer oligonucleotides and methods for their use |
| 04/30/2009 | US20090111092 Determination of hepatitis c virus genotype |
| 04/30/2009 | US20090111089 Primers and probes for detection and discrimination of types and subtypes of influenza viruses |
| 04/30/2009 | US20090110690 Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens |
| 04/30/2009 | US20090110685 Treatment and prevention of viral infections |
| 04/30/2009 | US20090110666 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 04/30/2009 | US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 04/30/2009 | US20090110639 Predicting vaccine efficacy |
| 04/30/2009 | CA2700522A1 Novel hiv targets |
| 04/30/2009 | CA2695237A1 Anti-rantes antibodies and methods of use thereof |
| 04/29/2009 | EP2053134A2 Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| 04/29/2009 | EP2051988A2 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 04/29/2009 | EP1866439A4 Methods and biomarkers for detecting nanoparticle exposure |
| 04/29/2009 | EP1601966B1 Methods and compositions for purification of nucleic acid from a host cell |
| 04/29/2009 | CN101421289A Method for removal of nucleic acid-protecting group |
| 04/29/2009 | CN101418045A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418044A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418043A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN100482674C Reduction of dermal scarring |
| 04/29/2009 | CN100482673C Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/28/2009 | US7524972 Synthetic molecules that specifically react with target sequences |
| 04/28/2009 | US7524950 Immobilization of nucleotide in microarray; dissolving in ink jet printhead solvent |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524948 Expression cassettes for vascular tissue-preferential expression in plants |
| 04/28/2009 | US7524947 Recombinant viral-based malaria vaccines |
| 04/28/2009 | US7524946 Isolated nucleic encoding antigenic proteins derived from Sarcocystis neurona, and sequences fully complementary to it; vectors comprising the nucleic acids |
| 04/28/2009 | US7524945 Comprises nucleotide sequences coding diacylglycerol acetyltransferases (DGAT) for transforming and generating plants with increased seed oil concentrations |
| 04/28/2009 | US7524943 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 04/28/2009 | US7524942 For analysis of ligated RNA |
| 04/28/2009 | US7524941 Methods for the preparation of chemically misaminoacylated tRNA via protective groups |
| 04/28/2009 | US7524931 Full-length interferon gamma polypeptide variants |
| 04/28/2009 | US7524927 Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524829 Specifically Ebola virus infections; antisense morpholino oligomer composed of morpholino subunits linked by phosphorous-containing intersubunit linkages which join a morpholino nitrogen of one subunit to a 5' exocyclic carbon of an adjacent subunit; target sequence within the AUG start site region |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524827 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a bcl-2 gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 04/28/2009 | US7524816 Peptides and supported peptides for treating skin diseases |
| 04/28/2009 | US7524675 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 04/28/2009 | US7524674 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera |
| 04/28/2009 | US7524667 Mutated 6-phosphogluconate dehydrogenase |
| 04/28/2009 | US7524666 Reductase gene and use thereof |
| 04/28/2009 | US7524665 Methods and compositions for vitamin K epoxide reductase |
| 04/28/2009 | US7524664 Regio- and enantioselective alkane hydroxylation with modified cytochrome P450 |
| 04/28/2009 | US7524660 Utilization of fructose in microbial production strains |
| 04/28/2009 | US7524659 Isogenic strain line of bacterium for producing polyhydroxyalkanoate in which polyhydroxyalkanoate synthase gene is disrupted and method for producing polyhydroxyalkanoate using the same |
| 04/28/2009 | US7524657 Alleles of the sigA gene from coryneform bacteria |
| 04/28/2009 | US7524656 Ability to produce L-glutamic acid, arginine or lysine is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 04/28/2009 | US7524653 Small interfering RNA libraries and methods of synthesis and use |
| 04/28/2009 | US7524652 Automated process for detecting the presence of a target nucleic acid in a sample |
| 04/28/2009 | US7524648 Expression system for enhancing solubility and immunogeneicity of recombinant proteins |
| 04/28/2009 | US7524644 Expression vector comprising enzymatic polypeptide for use in prevention and treatment of blood clots; thrombolytic agents |
| 04/28/2009 | US7524632 Species identification by melting analysis of secondary structure of single stranded nucleic acids |
| 04/28/2009 | US7524630 Silica-coated nanoparticles functionalized with biologically active molecules such as antibodies and nucleotides are used to label cells, to detect and isolate nucleic acid molecules having specific nucleotide sequences |
| 04/28/2009 | US7524629 Method for detecting cytosine methylation in DNA samples |
| 04/28/2009 | US7524505 Cell growth factor of hair stem cell factor induces migration of melanocyte stem cells and keratinocyte stem cells to increase in hair follicles, amino acids and vitamins, and minoxidil |
| 04/28/2009 | US7524498 Human immunomodulatory monoclonal antibodies for the treatment of cancer |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/28/2009 | US7524494 Degradation of hydrophobic ester pesticides and toxins |
| 04/28/2009 | US7524493 Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| 04/28/2009 | US7524492 Insulin related transcription factor and uses thereof |
| 04/28/2009 | US7524327 Light activated gene transduction using long wavelength ultraviolet light for cell targeted gene delivery |
| 04/28/2009 | CA2401727C Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 04/28/2009 | CA2252493C .beta.-galactoside - .alpha. 2,6-sialyltransferase gene |
| 04/28/2009 | CA2220195C Therapeutic oligonucleotides targeting the human mdr1 and mrp genes |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/28/2009 | CA2133017C Process for producing desired substance using acetic acid-resistant recombinant escherichia microorganism |
| 04/28/2009 | CA1341595C Procedure for obtaining dna, rna, peptides, polypeptides, or proteins byrecombinant dna techniques |
| 04/23/2009 | WO2009052422A1 Electrochemical assay for the detection of enzymes |
| 04/23/2009 | WO2009052128A1 Degenerate oligonucleotides and their uses |
| 04/23/2009 | WO2009052034A1 Synthesis of oligonucleotides or phosphorothioate oligonucleotide with a capping agent of n-methylimidazole free of 1,3,5-trimethylhexahydro-1,3,5-triazine |
| 04/23/2009 | WO2009050321A1 Laforin-based cancer diagnosis and treatment method, biological elements for implementing same and use thereof |
| 04/23/2009 | WO2009033094A3 Antibodies and related molecules that bind to 24p4c12 proteins |
| 04/23/2009 | WO2009026456A3 Poxvirus methods and compositions |
| 04/23/2009 | WO2009020771A3 Rnai agents comprising universal nucleobases |
| 04/23/2009 | WO2008147824A3 Hydroxymethyl substituted rna oligonucleotides and rna complexes |